Natural course of functional dyspepsia after Helicobacter pylori eradication: A seven-year survey

Digestive Diseases and Sciences

Volumn 50, Issue 12, 2005, Pages 2286-2295

  Di Mario, Francesco ^a   Stefani, Nicoletta ^a   Dal Bò, Nadia ^b   Rugge, Massimo ^c   Pilotto, Alberto ^d   Cavestro, Giulia Martina ^a   Cavallaro, Lucas Giovanni ^a   Franzè, Angelo ^e   Leandro, Gioacchino ^f  

^a UNIVERSITY OF PARMA   (Italy)

^b Unità di Gastroenterologia   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e Parma Hospital   (Italy)

^f NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Eradication; Functional dyspepsia; Helicobacter pylori

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

COURSE EVALUATION; DISEASE COURSE; DYSPEPSIA; ERADICATION THERAPY; FOLLOW UP; GASTRIC DYSMOTILITY; GASTROESOPHAGEAL REFLUX; HEALTH SURVEY; HELICOBACTER INFECTION; HUMAN; MEDICAL ASSESSMENT; PATHOPHYSIOLOGY; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW; STOMACH ULCER; STRUCTURED QUESTIONNAIRE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLUSTER ANALYSIS; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 30844448802     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-3049-z     Document Type: Review

References (39)

1. Talley NJ, Stanghellini V, Heading RC: Functional gastroduodenal disorders. Gut 45 (Suppl II):II37-II42, 1999
2. Nyren O, Lindberg G, Lindstrom E, Marke LA, Seensalu R: Economic costs of functional dyspepsia. Pharmacoeconomics 1:312-324, 1992
3. Drossman DA, Li Z, Andruzzi E, et al.: U.S. householder survey of functional gastrointestinal disorders: Prevalence, sociodemography and health impact. Dig Dis Sci 38:1569-1580, 1993
4. Jaakkimainen RL, Boyle E, Tudiver F: Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis. Br Med J 319:1040-1044, 1999
5. Danesh J, Pounder RE: Eradication of Helicobacter pylori and non-ulcer dyspepsia. Lancet 355:766-777, 2000
6. El-Serag HB, Talley NJ: Systematic review: The prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 19:643-654, 2004
7. Kawanishi M, Fukuda S, Kawaguchi H, Kohmoto K, Kajiyama G: Significance of rapid urease test for identification of Helicobacter pylori in comparison with histological and culture studies. J Gastroenterol 30:16-20, 1995
8. Colin-Jones DG, Bloom B, Bodemar G, et al.: Management of dyspepsia: Report of a working party. Lancet 1:576-579, 1988
9. International Agency for Research on Cancer: Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 61. Lyon, France: International Agency for Research on Cancer, 1994
10. Bonnevie O: Outcome of non-ulcer disease. Scand J Gastroenterol 17 (Suppl 79):135-138, 1982
11. Talley NJ, McNeill D, Hayen A, Colreavy C, Piper DW: Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed nonulcer dyspepsia. Gastroenterology 92:1060-1066, 1987
12. Talley NJ, Piper DW: A prospective study of social factors and major life event stress in patients with dyspepsia of unknown cause. Scand J Gastroenterol 22:268-272, 1987
13. Sloth H, Jorgensen LS: Predictors for the course of chronic non-organic upper abdominal pain. Scand J Gastroenterol 24:440-144, 1989
14. Hyams JS, Davis P, Sylvester FA, Zeiter DK, Justinich CJ, Lerer T: Dyspepsia in children and adolescents: A prospective study. J Pediatr Gastroenterol Nutr 30:413-418, 2000
15. Heikkinen M, Farkkila M: What is the long-term outcome of the different subgroups of functional dyspepsia? Aliment Pharmacol Ther 18:223-229, 2003
16. Hsu PI, Lai KH, Lo GH, et al.: Risk factors for ulcer development in patients with non-ulcer dispepsia: A prospective two year follow up study of 209 patients. Gut 51:15-20, 2002
17. Mc Carthy C, Patchett S, Collins RM, et al.: Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 40:114-119, 1995
18. Gilvarry J, Buckley MJ, Beattie S, et al.: Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 32:535-540, 1997
19. Sheu Bs, Lin CY, Lin XZ, et al.: Long-term outcome of triple therapy in Helicobacter pylori related non-ulcer dyspepsia: A prospective controlled assessment. Am J Gastroenterol 91:441-447, 1996
20. Lazzaroni M, Bargiggia S, Sangaletti O, et al.: Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study. Dig Dis Sci 41:1589-1594, 1996
21. McColl K, Murray L, El-Omar E, et al.: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. New Engl J Med 339:1869-1874, 1998
22. Chiba N, Veldhuyzen van Zanten SJO, Sinclair P, Ferguson RA, Escobedo S, Grace E: Treating Helicobacter pylori infection in primary care patients with univestigated dyspepsia: The Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial. Br Med J 324:1012, 2002
23. Elta GH, Scheiman JM, Barnett JL, et al.: Long-term follow-up of Helicobacter treatment in non-ulcer dyspepsia patients. Am J Gastroenterol 90:1089-1093, 1995
24. Veldhuyzen van Zanten SJ, Malatjalian D: The effect of eradication of Helicobacter pylor of symptoms of non-ulcer dyspepsia (NUD). A randomized, double-blind placebo-controlled trial. Gastroenterology 108:A250, 1995
25. Greenberg PD, Cello P: Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia. Arch Intern Med 159:2283-2288, 1999
26. Chuang CH, Sheu BS, Yang HB, et al.: Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylon-infected non-ulcer dyspepsia. Dig Liver Dis 33(2):125-130, 2001
27. Blum AL, Talley NJ, O'Morain C, et al.: Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus clarithromycin and amoxicillin effect one year after treatment (OCAY) study group. N Engl J Med 339:1875-1881, 1998
28. Froelich F, Gonvers JJ, Wietlisbach V, et al.: Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. Am J Gastroenterol 96:2329-2336, 2001
29. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E: Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 months' follow up. Br Med J 18:833-837, 1999
30. Talley NJ, Vakil N, Ballard ED, Fennery MB: Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 341:1106, 1999
31. Moayyedi P, Soo S, Deeks J, et al.: Systematic review and economic evaluation of Helicobacter pylori eradication treatment of non-ulcer dyspepsia. Br Med J 321:659-664, 2000
32. Moayyedi P, Soo S, Deeks J, et al.: Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 17:1215-1227, 2003
33. Williams D, O'Kelly P, Kelly A, Feely J: Lack of symptom benefit following presumptive Helicobacter pylori eradication therapy in primary care. Aliment Pharmacol Ther 15:1769-1775, 2001
34. Heikkinen M, Färkkilä M: Long-term outcome of functional dyspepsia: effect of Helicobacter pylori infection. A 6- to 7-year follow-up study. Scand J Gastroenterol 37:905-910, 2002
35. McNamara D, Buckley M, Gilvarry J, et al.: Does Helicobacter pylon eradication affects symptoms in nonulcer dyspepsia: A 5-year follow-up study. Helicobacter. 7:317-321, 2002
36. Hunt RH, Fallone CA, Thomson AB: Canadian Helicobacter pylori consensus conference update: Infection in adults. Can J Gastroenterol 13:213-217, 1999
37. Drossman DA, ed.: The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment. Boston, Little, Brown, 1994
38. Drossman DA, Talley NJ, Corazziari ES, Thompson WG, Whitehead WE, eds.: Rome II: The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment - A Multinational Consensus. 2nd ed. McLean, VA, Degnon Associates, 2000
39. Quigley EM: Non-erosive reflux disease: Part of the spectrum of gastro-oesophageal reflux disease, a component of functional dyspepsia, or both? Eur J Gastroenterol Hepatol 13 (Suppl 1):S13-S18, 2001